Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kineticsMie Fabricius Pedersen, Hans Bräuner‐Osborne, Tomasz M. Wróbel et al.|Neuropharmacology|2019Cited by 81
3-Substituted 2-phenyl-indoles: privileged structures for medicinal chemistryHenrik Johansson, Daniel Sejer Pedersen, Tanja Bøgeløv Jørgensen et al.|RSC Advances|2012Cited by 65
The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), α-, and β-melanocyte stimulating hormone (α-MSH, and β-MSH), and the conserved core motif HFRWAnne Cathrine Nøhr, Hans Bräuner‐Osborne, Mohamed A. Shehata et al.|Neurochemistry International|2016Cited by 46
Chemogenomic Discovery of Allosteric Antagonists at the GPRC6A ReceptorDavid E. Gloriam, Hans Bräuner‐Osborne, Petrine Wellendorph et al.|Chemistry & Biology|2011Cited by 42
1,2,3-Triazolyl amino acids as AMPA receptor ligandsNathan Stanley, Andrew D. Abell, Daniel Sejer Pedersen et al.|Bioorganic & Medicinal Chemistry Letters|2010Cited by 33